The FINANCIAL -- INDIANAPOLIS, Oct. 11, 2011  -- Eli Lilly and Company today announced key appointments due to the December 31 retirements of longtime senior leaders, Bryce D. Carmine and Frank Deane, Ph.D.

Carmine, whose Lilly career spans 36 years, has led Lilly Bio-Medicines since its creation in 2009. And Deane, whose career at Lilly spans 33 years, has led global manufacturing operations since 2007. Previously, both held numerous high-level leadership posts around the globe.

John C. Lechleiter, Ph.D., chairman, president, and chief executive officer, described Carmine and Deane as "pillars of the company who have had a lasting, worldwide impact on our people and our business. We're grateful for their dedicated service."

Related Stories

• Innovative public-private collaboration launches to tackle antibiotic research
• Phase II Trial Used Ambulatory Blood Pressure Monitoring to Evaluate Blood Pressure
• Pharmacyclics Announces Oral Presentations of Ibrutinib